相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Captopril and Lisinopril Only Inhibit Matrix Metalloproteinase-2 (MMP-2) Activity at Millimolar Concentrations
Luciana B. Kuntze et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR
Raquel C. Antonio et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo
Changcun Fang et al.
CARDIOVASCULAR RESEARCH (2013)
Membrane-Associated Matrix Proteolysis and Heart Failure
Francis G. Spinale et al.
CIRCULATION RESEARCH (2013)
Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy
Elen Rizzi et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
Carla S. Ceron et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes
Elen Rizzi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling
Alisson Martins-Oliveira et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats
P. R. Nagareddy et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension
Vanessa Fontana et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Regulation of the Inflammatory Response in Cardiac Repair
Nikolaos G. Frangogiannis
CIRCULATION RESEARCH (2012)
Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction
Lennart Nilsson et al.
HEART (2012)
Loss of Timp3 Gene Leads to Abdominal Aortic Aneurysm Formation in Response to Angiotensin II
Ratnadeep Basu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli
Andrezza N. Goncalves et al.
JOURNAL OF BIOTECHNOLOGY (2012)
Myofibroblasts in the Infarct Area: Concepts and Challenges
Evangelos P. Daskalopoulos et al.
MICROSCOPY AND MICROANALYSIS (2012)
Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension
Carla S. Ceron et al.
MATRIX BIOLOGY (2012)
Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability
Michele M. Castro et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2012)
A Novel Intracellular Isoform of Matrix Metalloproteinase-2 Induced by Oxidative Stress Activates Innate Immunity
David H. Lovett et al.
PLOS ONE (2012)
Matrix metalloproteinases in vascular physiology and disease
Suzanne A. Siefert et al.
VASCULAR (2012)
Epithelial-Mesenchymal Transition: General Principles and Pathological Relevance with Special Emphasis on the Role of Matrix Metalloproteinases
Paola Nistico et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Contribution of oxidative stress to endothelial dysfunction in hypertension
Bruno R. Silva et al.
FRONTIERS IN PHYSIOLOGY (2012)
Doxycycline Dose-dependently Inhibits MMP-2-Mediated Vascular Changes in 2K1C Hypertension
Danielle A. Guimaraes et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target
Vanessa Fontana et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension
S. B. A. Cau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Doxycycline Ameliorates Vascular Endothelial and Contractile Dysfunction in the Thoracic Aorta of Diabetic Rats
Esma N. Zeydanli et al.
CARDIOVASCULAR TOXICOLOGY (2011)
Targeted Imaging of the Spatial and Temporal Variation of Matrix Metalloproteinase Activity in a Porcine Model of Postinfarct Remodeling Relationship to Myocardial Dysfunction
Zakir H. Sahul et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2011)
Nuclear Factor Kappa B and Matrix Metalloproteinase Induced Receptor Cleavage in the Spontaneously Hypertensive Rat
Kwan-I Sharon Wu et al.
HYPERTENSION (2011)
Transgenic expression of matrix metalloproteinase-2 induces coronary artery ectasia
Sia Dahi et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2011)
Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model
Karina M. Mata et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2011)
Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
Diogo M. O. Marcal et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Cellular/extracellular matrix cross-talk in scar evolution and control
Alan D. Widgerow
WOUND REPAIR AND REGENERATION (2011)
Matrix metalloproteinases cleave the β2-adrenergic receptor in spontaneously hypertensive rats
Stephen F. Rodrigues et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension
C. S. Ceron et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression
Laurie E. Littlepage et al.
CANCER RESEARCH (2010)
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
Paras K. Mishra et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Titin is a Target of Matrix Metalloproteinase-2 Implications in Myocardial Ischemia/Reperfusion Injury
Mohammad A. M. Ali et al.
CIRCULATION (2010)
Captopril directly inhibits matrix metalloproteinase-2 activity in continuous ambulatory peritoneal dialysis therapy
Daisuke Yamamoto et al.
CLINICA CHIMICA ACTA (2010)
Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction
Francis G. Spinale et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension
Elen Rizzi et al.
JOURNAL OF CARDIAC FAILURE (2010)
The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction
Marcin Dobaczewski et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Enhanced Matrix Metalloproteinase Activity in the Spontaneously Hypertensive Rat: VEGFR-2 Cleavage, Endothelial Apoptosis, and Capillary Rarefaction
Edward D. Tran et al.
JOURNAL OF VASCULAR RESEARCH (2010)
Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension
Elen Rizzi et al.
ARCHIVES OF TOXICOLOGY (2009)
Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione
Serena Viappiani et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease
Rajeev Mahimkar et al.
CARDIOVASCULAR PATHOLOGY (2009)
A Role of Matrix Metalloproteinase-8 in Atherosclerosis
Ross C. Laxton et al.
CIRCULATION RESEARCH (2009)
Cardiac-Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase in Mice Effects on Myocardial Remodeling With Aging
Francis G. Spinale et al.
CIRCULATION-HEART FAILURE (2009)
Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy
Andrea M. Marcaccini et al.
CLINICA CHIMICA ACTA (2009)
Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness
Stefania Piconi et al.
FASEB JOURNAL (2009)
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
Michele M. Castro et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis
P-O. Soder et al.
JOURNAL OF PERIODONTAL RESEARCH (2009)
Effects of Tick Control by Acaricide Self-Treatment of White-Tailed Deer on Host-Seeking Tick Infection Prevalence and Entomologic Risk for Ixodes scapularis-Borne Pathogens
Anne Gatewood Hoen et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2009)
Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits
Sohsuke Yamada et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
Michele A. Castro et al.
ATHEROSCLEROSIS (2008)
Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats
Marcio L. L. Martinez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
Marcio L. L. Martinez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells
Sharon Elliot et al.
EXPERIMENTAL EYE RESEARCH (2008)
The chemical biology of nitric oxide: Implications in cellular signaling
Douglas D. Thomas et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Proteinase activity and receptor cleavage -: Mechanism for insulin resistance in the spontaneously hypertensive rat
Frank A. DeLano et al.
HYPERTENSION (2008)
Metalloproteinase Expression in Carotid Plaque and Its Correlation With Plasma Levels Before and After Carotid Endarterectomy
Maurizio Taurino et al.
Vascular and Endovascular Surgery (2008)
Matrix metalloproteinase-2 degrades the cytoskeletal protein α-actinin in peroxynitrite mediated myocardial injury
Miranda M. Sung et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation
Meltem Sariahmetoglu et al.
FASEB JOURNAL (2007)
Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction
Hui-Zhong Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure
Gregory L. Brower et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Plaque neovascularization and antiangiogenic therapy for atherosclerosis
Brendan Doyle et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction
Marina R. Bergman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study
Dominic Kelly et al.
EUROPEAN HEART JOURNAL (2007)
Doxycycline affects diet- and bacteria-associated atherosclerosis in an ApoE heterozygote murine model: Cytokine profiling implications
Monika Madan et al.
ATHEROSCLEROSIS (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Mice lacking the gene encoding for MMP-9 and resistance artery reactivity
Jun Su et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation
Wanfen Xiong et al.
JOURNAL OF VASCULAR SURGERY (2006)
Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction
Rupak Mukherjee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis
Karim Si-Tayeb et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB
Maria Alejandra Alfonso-Jaume et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Periodontal infections and cardiovascular disease - The heart of the matter
Ryan T. Demmer et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2006)
Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction - Relation to left ventricular remodeling
Carson S. Webb et al.
CIRCULATION (2006)
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury
Sunfa Cheng et al.
FASEB JOURNAL (2006)
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction
ML Lindsey et al.
CIRCULATION (2006)
Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
SH Ahmed et al.
CIRCULATION (2006)
Effect of MMP-2 deficiency on atherosclerotic lesion formation in ApoE-deficient mice
M Kuzuya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload
H Matsusaka et al.
HYPERTENSION (2006)
Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults
D Martin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors
JT Peterson
CARDIOVASCULAR RESEARCH (2006)
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction
ML Lindsey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase
LM Bevers et al.
HYPERTENSION (2006)
Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction
A Tessone et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling
HL Su et al.
CIRCULATION (2005)
Divergent effects of matrix metalloproteinase-3, metalloproteinase-7, metalloproteinase-9, and metalloproteinase-12 on atherosclerotic plaque stability in mouse brachiocephalic arteries
JL Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Atherosclerotic plaque progression and vulnerability to rupture - Angiogenesis as a source of intraplaque hemorrhage
R Virmani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease
TC Wu et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
α-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy
R Alleva et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury - A new intracellular target for matrix metalloproteinase-2
G Sawicki et al.
CIRCULATION (2005)
Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm
WRW Wilson et al.
BRITISH JOURNAL OF SURGERY (2005)
Elevated circulating levels of matrix metalloproteinase-9 and-2 in patients with symptomatic coronary artery disease
B Zeng et al.
INTERNAL MEDICINE JOURNAL (2005)
MMP-12 has a role in abdominal aortic aneurysms in mice
GM Longo et al.
SURGERY (2005)
Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition
C Bouvet et al.
HYPERTENSION (2005)
Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP
A Robinet et al.
JOURNAL OF CELL SCIENCE (2005)
Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition
JS Ikonomidis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial
DL Brown et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth
A Luttun et al.
CIRCULATION (2004)
Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway
L Hao et al.
CIRCULATION RESEARCH (2004)
Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis
B Alvarez et al.
JOURNAL OF VASCULAR SURGERY (2004)
Pathologic assessment of the vulnerable human coronary plaque
FD Kolodgie et al.
HEART (2004)
MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix
TH Chun et al.
JOURNAL OF CELL BIOLOGY (2004)
Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice
FC Gibson et al.
CIRCULATION (2004)
Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator
A Martínez et al.
BIOCHEMICAL JOURNAL (2004)
Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarction
J Renko et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2004)
Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics
AR Morgan et al.
STROKE (2004)
Matrix metalloproteinase inhibitor development and the remodeling of drug discovery
JT Peterson
HEART FAILURE REVIEWS (2004)
Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy
T Mustoe
AMERICAN JOURNAL OF SURGERY (2004)
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling
WM Yarbrough et al.
CIRCULATION (2003)
Serum metalloproteinase 9 levels in patients with coronary artery disease: A novel marker of inflammation
P Ferroni et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2003)
Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats
TM Camp et al.
JOURNAL OF HYPERTENSION (2003)
Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice
E Lalla et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP)
JR Worley et al.
BIOCHEMICAL JOURNAL (2003)
Identification of a region of β-amyloid precursor protein essential for its gelatinase a inhibitory activity
S Higashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis
KS Moulton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease
S Blankenberg et al.
CIRCULATION (2003)
Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses
M Ide et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2003)
Selective matrix metalloproteinase inhibition with developing heart failure - Effects on left ventricular function and structure
MK King et al.
CIRCULATION RESEARCH (2003)
Myocardial infarct expansion and matrix metalloproteinase inhibition
R Mukherjee et al.
CIRCULATION (2003)
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers
MR Bergman et al.
BIOCHEMICAL JOURNAL (2003)
Cardiac remodelling in end stage heart failure:: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP
D Reinhardt et al.
HEART (2002)
Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration arterial remodeling and geometrical
ZS Galis et al.
CIRCULATION RESEARCH (2002)
Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury
WJ Wang et al.
CIRCULATION (2002)
Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis
MJ Novak et al.
JOURNAL OF PERIODONTOLOGY (2002)
MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells
N Huo et al.
CANCER LETTERS (2002)
Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model
L Li et al.
CIRCULATION (2002)
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
A Pozzi et al.
ONCOGENE (2002)
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease
A Kalela et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2002)
Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion
Y Itoh et al.
EMBO JOURNAL (2001)
Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation
T Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Catcholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment
M Carmignani et al.
LIFE SCIENCES (2000)
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction
C Fernandez-Patron et al.
CIRCULATION RESEARCH (2000)
TIMP-2 is required for efficient activation of proMMP-2 in vivo
ZP Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The oral cavity as a reservoir of bacterial pathogens for focal infections
R Gendron et al.
MICROBES AND INFECTION (2000)
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
A Ducharme et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
The change of β-adrenergic system in lead-induced hypertension
DA Tsao et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2000)
分享论文
